Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Role of EGb 761 in the Syndrome of Mild Cognitive Impairment With Concomitant Cerebrovascular Disease (MCI + CVD)

NCT04525144 is registered in ClinicalTrials.gov with National Neuroscience Institute as lead sponsor.

NCT NCT04525144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04525144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Role of EGb 761 in the Syndrome of Mild Cognitive Impairment With Concomitant Cerebrovascular Disease (MCI + CVD)
Lead sponsor
National Neuroscience Institute
Phase
Phase 2
Overall status
Recruiting
Start date
October 26, 2020
Completion date
November 30, 2026
Enrollment
134 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular disease, mild cognitive impairment